These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 913117)

  • 1. Clinical pharmacology of flurbiprofen: a novel inhibitor of platelet aggregation.
    Thebault JJ; Lagrue G; Blatrix CE; Cheynier L; Cluzan R
    Curr Med Res Opin; 1977; 5(1):130-4. PubMed ID: 913117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of flurbiprofen (2-(2-fluoro-4-biphenylyl) propionic acid) on platelet function and blood coagulation.
    Davies T; Lederer DA; Spencer AA; McNicol GP
    Thromb Res; 1974 Nov; 5(5):667-83. PubMed ID: 4445988
    [No Abstract]   [Full Text] [Related]  

  • 3. Relative effects of flurbiprofen on platelet 12-hydroxy-eicosatetraenoic acid and thromboxane A2 production: influence on collagen-induced platelet aggregation and adhesion.
    Van Ryan-McKenna J; Buchanan MR
    Prostaglandins Leukot Essent Fatty Acids; 1989 Jun; 36(3):171-4. PubMed ID: 2780761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat.
    Clowes AW; Karnovsky MJ
    Lab Invest; 1977 Apr; 36(4):452-64. PubMed ID: 846193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
    Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
    J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ticlopidine, a new platelet aggregation inhibitor in man.
    Thebault JJ; Blatrix CE; Blanchard JF; Panak EA
    Clin Pharmacol Ther; 1975 Oct; 18(4):485-90. PubMed ID: 1100310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the effect of flurbiprofen (2-(2-fluoro-4-biphenylyl) propionic acid) on platelet behaviour.
    Sim AK; McCraw AP; Sim MF
    Thromb Res; 1975 Oct; 7(4):655-68. PubMed ID: 1198551
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro evaluation of inhibitors of platelet release and aggregation.
    Rosenberg JC; Sell TL
    Arch Surg; 1975 Aug; 110(8):980-3. PubMed ID: 168838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suloctidil: a novel inhibitor of platelet aggregation in human beings.
    de Gaetano G; Miragliotta G; Roncucci R; Lansen J; Lambelin G
    Thromb Res; 1976 Mar; 8(3):361-71. PubMed ID: 1265708
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of three dosage schedules of flurbiprofen on platelet function and coagulation.
    Gupta KC; Paul T; Manikeri S; Kulkarni VN; Pispati PK; Sheth UK
    Indian J Med Res; 1980 Sep; 72():434-40. PubMed ID: 7007228
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation].
    Sakata T; Kobayashi K; Katayama Y; Takada T; Matsuyama T
    Rinsho Byori; 1991 Mar; 39(3):315-20. PubMed ID: 2051607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of RH-8, flurbiprofen and aspirin on platelet function and coagulation.
    Gupta KC; Manikeri S; Paul T; Tilve GH; Acharya VN; Mehta JM; Sheth UK
    Indian J Med Res; 1979 Jan; 69():181-8. PubMed ID: 429023
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of flurbiprofen on platelet aggregation. I. Metabolic and ultrastructural studies in vitro.
    Abe T; Goto H; Imaoka S; Inoshita K; Kazama M; Kosaki G; Matsumoto A; Nakamura K; Ryo R; Shinkai A; Tomita Y; Yamada K; Yasunaga K; Wada T
    Nihon Ketsueki Gakkai Zasshi; 1978 Feb; 41(1):111-26. PubMed ID: 735688
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of flurbiprofen on bleeding time and platelet aggregation.
    Pitney WR; Nicol M; Dean S; Hickey A
    Thromb Res; 1978 Nov; 13(5):811-9. PubMed ID: 741454
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of 6-[p-(4-phenylacetylpiperazin-1-yl)phenyl]-4,5-dihydro-3(2H)pyridazinone (CCI 17810) and aspirin on platelet aggregation and adhesiveness.
    Griffett EM; Kinnon SM; Kumar A; Lecker D; Smith GM; Tomich EG
    Br J Pharmacol; 1981 Apr; 72(4):697-705. PubMed ID: 7284687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet release and aggregation induced by antithymocyte globulin. In vitro effect of inhibitors.
    Rosenberg JC; Sell T
    Transplantation; 1975 Oct; 20(4):346-50. PubMed ID: 169611
    [No Abstract]   [Full Text] [Related]  

  • 17. 6-methyl-1,2,3,5-tetrahydroimidazo(2,1-b)quinazolin-2-one, a potent inhibitor of ADP-induced platelet aggregation.
    Beverung WN; Partyka RA
    J Med Chem; 1975 Feb; 18(2):224-5. PubMed ID: 1120996
    [No Abstract]   [Full Text] [Related]  

  • 18. [The inhibitory effect of oxaprozin, a new non-steroidal anti-inflammatory drug, on platelet aggregation].
    Goto J; Muramatsu M; Hosoda K; Otomo S; Aihara H
    Nihon Yakurigaku Zasshi; 1984 May; 83(5):395-400. PubMed ID: 6432657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet adhesiveness, thromboelastogram, prothrombin activity and partial thromboplastin time during treatment with flurbiprofen.
    Cremoncini C; Vignati E; Valente C; Dossena MG
    Curr Med Res Opin; 1977; 5(1):135-40. PubMed ID: 913118
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
    Carter AJ; Heptinstall S
    Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.